Sun, Jul 5, 2015
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Private Equity Strategies

Dealmakers Q&A: Waud Capital Merges Portfolio Companies Early On

Monday, August 26, 2013

By: Bailey McCann, Private Equity Strategies

Waud Capital Partners focuses on middle-market growth equity investments, buyouts, industry consolidations and recapitalizations. Since its founding in 1993, the firm has completed more than 150 investments across industries, and has approximately $1bn of capital under management.

The firm recently announced the merger of two of its portfolio companies - Adreima and Optimum Outcomes, marking the first time Waud has merged two of its own portfolio companies. The merger is also notable as it took place early on in the investment lifecycle, which means that Waud will continue to be involved with the new entity well into the future.

“We always thought that there was a possibility both companies could be merged, but it was never a specific plan,” explains David Neighbours, Partner at Waud Capital Partners, in an interview with Private Equity Strategies. “We found there was a great opportunity to combine services, and share customers between the two businesses in a way that would be beneficial for both companies and their customers.”

Adreima, is a national provider of clinically integrated revenue cycle services. Optimum Outcomes, is a national provider of patient-focused account resolution services. Both companies have a roughly similar target audience of 5-6,000 hospitals in the US. The companies focus on the revenue cycle of hospitals, providing services around eligibility and registration staffing; clinical audit and denial prevention; and receivables management and self-pay/bad debt account resolution.

Both companies have been serving their respective clients for a number of years, Adreima was founded in 1990, and Optimum has been in business for 25 years.

Waud itself is a generalist firm in terms of the portfolio companies it looks at, however, Neighbors notes that they have a significant health care group and will continue to pursue this industry. The firm typically invests $20-100m, as a controlling interest. From there, Waud looks at how it can best grow portfolio companies, in this case that growth came from being acutely aware of how two separate portfolio companies work together in the same industry.

“Over time, merging the two companies really started to become a natural thing to do as they both evolved and started working together,” Neighbours says. “This will allow us to expand services to customers, and entrench those services, making it harder for hospitals to switch vendors.”

“We are acutely aware that each touch point of a patient’s healthcare experience has the ability to influence that patient’s perception of the provider. With the full spectrum of services now offered by the combined company, we are even better positioned to ensure and facilitate a positive patient experience, from initial registration all the way through final account resolution,” says Robb Cass, President of Optimum Outcomes.

The combined company will maintain the Adreima name and will be headquartered in suburban Chicago. The new business will have 1,100 dedicated employees, including 200 specialized physicians, nurses and coders, serving 600 hospitals and providers across 36 states. Robert Willhelm, the current CEO of Adreima will be CEO of this iteration, and Robb Cass, current President of Optimum Outcomes, will lead the patient-focused account resolution division.

The new organization will continue to operate from seven regional locations (Phoenix, Raleigh, Jacksonville, Fort Lauderdale, Los Angeles, Birmingham and Bloomfield, New Jersey). The company’s bad debt division will continue to operate as Optimum Outcomes.

“This is the first time we’ve ever merged two companies we have invested in so we plan to spend the balance of 2013 focusing on integration. In 2014 we will look at ways to continue growth, potentially through new acquisition opportunities, this is still a long term investment for us,” Neighbours says.

Waud had a controlling interest in both companies before the merger, and will maintain a controlling interest in the merged entity. Debt financing for the merger was provided by BMO, Regions Bank, Capital One Bank and Bregal Sagemount.

 
This article was published in Opalesque's Private Equity Strategies our monthly research update on the global private equity landscape including all sectors and market caps.
Private Equity Strategies
Private Equity Strategies
Private Equity Strategies
Private Equity Strategies


Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Opalesque Exclusive: New systematic strategy managed alongside research firm outperforms S&P500[more]

    Benedicte Gravrand, Opalesque Geneva for New Managers: An emerging CTA manager explains how he runs his strategy, which is based on an index produced by a research firm. Peter Turk is head of

  2. Opalesque Exclusive: New systematic strategy embraces machine learning[more]

    Benedicte Gravrand, Opalesque Geneva for New Managers: The founder of a New York-based systematic trading firm, which offers a hybrid between alpha strategies and alternative feta at lower fees, describes his approa

  3. Larry Robbins' hedge fund Glenview buys 1m Tenet Healthcare shares[more]

    Komfie Manalo, Opalesque Asia: Glenview Capital Management said it bought an additional 979,482 shares at Tenet Healthcare Corp valued at $53.80 million, raising its stakes in the healthcare services company to 15.16%, reported

  4. Legal - Grayson’s hedge funds under scrutiny for possible ethics violations, Court rejects hedge fund’s motion to block merger of Samsung affiliates[more]

    Grayson’s hedge funds under scrutiny for possible ethics violations From Freebeacon.com: Rep. Alan Grayson is finding himself in hot water over managing hedge funds that bear his name, actions that are in possible violation of House ethics rules. Sitting members of Congress are prohibite

  5. Hedge funds decline in June as stocks tumble on Greek woes[more]

    From Bloomberg.com: Hedge funds posted losses across strategies last month as uncertainty over whether Greece will remain in the euro sent global stock markets tumbling. Winton Capital Management declined about 3.1 percent in June in its $12.1 billion Winton Futures Fund, leaving it down 1.9 percent

banner